Hausfater, Pierre https://orcid.org/0000-0002-7716-6354
Robert Boter, Neus
Morales Indiano, Cristian
Cancella de Abreu, Marta
Marin, Adria Mendoza
Pernet, Julie
Quesada, Dolores
Castro, Iris
Careaga, Diana
Arock, Michel
Tejidor, Liliana
Velly, Laetitia
Article History
Received: 17 March 2021
Accepted: 31 May 2021
First Online: 30 June 2021
Declarations
:
: The study was registered in ClinicalTrials.gov (NCT03588325) and approved by the ethical committees of the respective participating countries. Patients were included after informed consent. Study was approved by: Agence nationale de sécurité du médicament et des produits de santé (ANSM), July 02, 2018, and by the Comité de Protection des Personnes (CPP) July 16, 2018. REF. 2018-A00892-53 Paris, France. Comités de Ética de la Investigación (CEI), Hospital Universitari Germans Trias i Pujol, June 22, 2018. REF.CEI PI-18-140 Badalona, Spain.
: NA.
: PH receive consultant and advisory board fees from Beckman Coulter, educational support and congress communication fees from ThermoFisher Scientific, Radiometer and bioMérieux. IC, DC and LT are employed by Beckman Coulter, Inc., the sponsor of the clinical study. The other authors have no conflict of interest or competing interest to declare.